201 related articles for article (PubMed ID: 27993549)
1. Higher Nevus Count Exhibits a Distinct DNA Methylation Signature in Healthy Human Skin: Implications for Melanoma.
Roos L; Sandling JK; Bell CG; Glass D; Mangino M; Spector TD; Deloukas P; Bataille V; Bell JT
J Invest Dermatol; 2017 Apr; 137(4):910-920. PubMed ID: 27993549
[TBL] [Abstract][Full Text] [Related]
2. Melanocytic nevi, nevus genes, and melanoma risk in a large case-control study in the United Kingdom.
Newton-Bishop JA; Chang YM; Iles MM; Taylor JC; Bakker B; Chan M; Leake S; Karpavicius B; Haynes S; Fitzgibbon E; Elliott F; Kanetsky PA; Harland M; Barrett JH; Bishop DT
Cancer Epidemiol Biomarkers Prev; 2010 Aug; 19(8):2043-54. PubMed ID: 20647408
[TBL] [Abstract][Full Text] [Related]
3. Associations of 9p21 variants with cutaneous malignant melanoma, nevi, and pigmentation phenotypes in melanoma-prone families with and without CDKN2A mutations.
Yang XR; Liang X; Pfeiffer RM; Wheeler W; Maeder D; Burdette L; Yeager M; Chanock S; Tucker MA; Goldstein AM
Fam Cancer; 2010 Dec; 9(4):625-33. PubMed ID: 20574843
[TBL] [Abstract][Full Text] [Related]
4. Genome-wide association study identifies variants at 9p21 and 22q13 associated with development of cutaneous nevi.
Falchi M; Bataille V; Hayward NK; Duffy DL; Bishop JA; Pastinen T; Cervino A; Zhao ZZ; Deloukas P; Soranzo N; Elder DE; Barrett JH; Martin NG; Bishop DT; Montgomery GW; Spector TD
Nat Genet; 2009 Aug; 41(8):915-9. PubMed ID: 19578365
[TBL] [Abstract][Full Text] [Related]
5. Phenotypic characterization of nevus and tumor patterns in MITF E318K mutation carrier melanoma patients.
Sturm RA; Fox C; McClenahan P; Jagirdar K; Ibarrola-Villava M; Banan P; Abbott NC; Ribas G; Gabrielli B; Duffy DL; Peter Soyer H
J Invest Dermatol; 2014 Jan; 134(1):141-149. PubMed ID: 23774529
[TBL] [Abstract][Full Text] [Related]
6. Genome-wide association study identifies nidogen 1 (NID1) as a susceptibility locus to cutaneous nevi and melanoma risk.
Nan H; Xu M; Zhang J; Zhang M; Kraft P; Qureshi AA; Chen C; Guo Q; Hu FB; Rimm EB; Curhan G; Song Y; Amos CI; Wang LE; Lee JE; Wei Q; Hunter DJ; Han J
Hum Mol Genet; 2011 Jul; 20(13):2673-9. PubMed ID: 21478494
[TBL] [Abstract][Full Text] [Related]
7. DNA-methylation profiling distinguishes malignant melanomas from benign nevi.
Conway K; Edmiston SN; Khondker ZS; Groben PA; Zhou X; Chu H; Kuan PF; Hao H; Carson C; Berwick M; Olilla DW; Thomas NE
Pigment Cell Melanoma Res; 2011 Apr; 24(2):352-60. PubMed ID: 21375697
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of MITF p.E318K in Patients With Melanoma Independent of the Presence of CDKN2A Causative Mutations.
Potrony M; Puig-Butille JA; Aguilera P; Badenas C; Tell-Marti G; Carrera C; Javier Del Pozo L; Conejo-Mir J; Malvehy J; Puig S
JAMA Dermatol; 2016 Apr; 152(4):405-12. PubMed ID: 26650189
[TBL] [Abstract][Full Text] [Related]
9. Identification of a Robust Methylation Classifier for Cutaneous Melanoma Diagnosis.
Conway K; Edmiston SN; Parker JS; Kuan PF; Tsai YH; Groben PA; Zedek DC; Scott GA; Parrish EA; Hao H; Pearlstein MV; Frank JS; Carson CC; Wilkerson MD; Zhao X; Slater NA; Moschos SJ; Ollila DW; Thomas NE
J Invest Dermatol; 2019 Jun; 139(6):1349-1361. PubMed ID: 30529013
[TBL] [Abstract][Full Text] [Related]
10. RASSF10 promoter hypermethylation is frequent in malignant melanoma of the skin but uncommon in nevus cell nevi.
Helmbold P; Richter AM; Walesch S; Skorokhod A; Marsch WCh; Enk A; Dammann RH
J Invest Dermatol; 2012 Mar; 132(3 Pt 1):687-94. PubMed ID: 22113481
[TBL] [Abstract][Full Text] [Related]
11. No association between telomere length-related loci and number of cutaneous nevi.
Li X; Liang G; Du M; De Vivo I; Nan H
Oncotarget; 2016 Dec; 7(50):82396-82399. PubMed ID: 27637081
[TBL] [Abstract][Full Text] [Related]
12. IRF4 variants have age-specific effects on nevus count and predispose to melanoma.
Duffy DL; Iles MM; Glass D; Zhu G; Barrett JH; Höiom V; Zhao ZZ; Sturm RA; Soranzo N; Hammond C; Kvaskoff M; Whiteman DC; Mangino M; Hansson J; Newton-Bishop JA; ; Bataille V; Hayward NK; Martin NG; Bishop DT; Spector TD; Montgomery GW
Am J Hum Genet; 2010 Jul; 87(1):6-16. PubMed ID: 20602913
[TBL] [Abstract][Full Text] [Related]
13. Promoter CpG island hypermethylation in dysplastic nevus and melanoma: CLDN11 as an epigenetic biomarker for malignancy.
Gao L; van den Hurk K; Moerkerk PTM; Goeman JJ; Beck S; Gruis NA; van den Oord JJ; Winnepenninckx VJ; van Engeland M; van Doorn R
J Invest Dermatol; 2014 Dec; 134(12):2957-2966. PubMed ID: 24999589
[TBL] [Abstract][Full Text] [Related]
14. Epidermal growth factor gene (EGF) polymorphism and risk of melanocytic neoplasia.
James MR; Hayward NK; Dumenil T; Montgomery GW; Martin NG; Duffy DL
J Invest Dermatol; 2004 Oct; 123(4):760-2. PubMed ID: 15373782
[TBL] [Abstract][Full Text] [Related]
15. High naevus count and MC1R red hair alleles contribute synergistically to increased melanoma risk.
Duffy DL; Lee KJ; Jagirdar K; Pflugfelder A; Stark MS; McMeniman EK; Soyer HP; Sturm RA
Br J Dermatol; 2019 Nov; 181(5):1009-1016. PubMed ID: 30820946
[TBL] [Abstract][Full Text] [Related]
16. The role of MC1R gene variants and phenotypical features in predicting high nevus count.
van der Poel LAJ; Bergman W; Gruis NA; Kukutsch NA
Melanoma Res; 2020 Oct; 30(5):511-514. PubMed ID: 32732695
[TBL] [Abstract][Full Text] [Related]
17. Melanocortin 1 receptor (MC1R) polymorphisms' influence on size and dermoscopic features of nevi.
Vallone MG; Tell-Marti G; Potrony M; Rebollo-Morell A; Badenas C; Puig-Butille JA; Gimenez-Xavier P; Carrera C; Malvehy J; Puig S
Pigment Cell Melanoma Res; 2018 Jan; 31(1):39-50. PubMed ID: 28950052
[TBL] [Abstract][Full Text] [Related]
18. Combining common genetic variants and non-genetic risk factors to predict risk of cutaneous melanoma.
Gu F; Chen TH; Pfeiffer RM; Fargnoli MC; Calista D; Ghiorzo P; Peris K; Puig S; Menin C; De Nicolo A; Rodolfo M; Pellegrini C; Pastorino L; Evangelou E; Zhang T; Hua X; DellaValle CT; Timothy Bishop D; MacGregor S; Iles MI; Law MH; Cust A; Brown KM; Stratigos AJ; Nagore E; Chanock S; Shi J; Consortium MM; Consortium M; Landi MT
Hum Mol Genet; 2018 Dec; 27(23):4145-4156. PubMed ID: 30060076
[TBL] [Abstract][Full Text] [Related]
19. American Academy of Dermatology 1999 Awards for Young Investigators in Dermatology. The prevalence of CDKN2A in patients with atypical nevi and malignant melanoma.
Ung-Juurlink C
J Am Acad Dermatol; 1999 Sep; 41(3 Pt 1):461-2. PubMed ID: 10507913
[No Abstract] [Full Text] [Related]
20. Influence of genes, nevi, and sun sensitivity on melanoma risk in a family sample unselected by family history and in melanoma-prone families.
Chaudru V; Chompret A; Bressac-de Paillerets B; Spatz A; Avril MF; Demenais F
J Natl Cancer Inst; 2004 May; 96(10):785-95. PubMed ID: 15150307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
